GlassScriptPhysician profile
Jean Haspel
NPI 1932146750
$5,934.95
in general payments reported to CMS, 2019-2025
12 companies · $1,503 in 2025
The $1,503 reported for 2025 was more than what 91% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,121 · 2022: $1,135 · 2023: $1,185 · 2024: $992 · 2025: $1,503.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,660 · Education: $19.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,659.65 |
| Education | $19.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $1,752.84 | 2021-2025 | Biktarvy, Sunlenca, Epclusa |
| Viiv Healthcare Company | $1,562.81 | 2021-2025 | Cabenuva, Dovato, Apretude |
| Abbvie INC. | $623.86 | 2021-2025 | |
| Braeburn INC. | $539.35 | 2023-2025 | Brixadi |
| Alkermes, INC. | $526.69 | 2021-2025 | Vivitrol, Vivitrol |
| Theratechnologies INC. | $412.78 | 2023-2025 | Egrifta Sv, Trogarzo, Egrifta |
| Merck Sharp & Dohme LLC | $315.90 | 2021-2023 | Delstrigo, Pifeltro |
| Indivior INC. | $76.84 | 2021-2025 | Sublocade |
| Janssen Products, LP | $49.95 | 2021 | |
| Janssen Biotech, INC. | $30.98 | 2021 | |
| Exact Sciences Corporation | $25.83 | 2025 | Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $17.12 | 2024 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jean Haspel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.